Purchasers Blast Wyeth's Immunity Bid In Pay-For-Delay Suit

By Allissa Wickham (June 19, 2014, 8:54 PM EDT) -- A class of direct purchasers accusing Wyeth LLC and Teva Pharmaceuticals USA Inc. of making an anti-competitive deal to delay a generic version of the antidepressant Effexor XR criticized Wyeth on Thursday for trying to use an old consent decree to bolster its immunity argument, claiming the decree was brought up too late....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!